A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country.

doi:10.1007/s10096-023-04693-8

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology - 1 Jan 2024

Pinhata Juliana Maira Watanabe, Ferrazoli Lucilaine, Mendes Flávia de Freitas, Gonçalves Maria Gisele, Rabello Michelle Christiane da Silva, Ghisi Kelen Teixeira, Simonsen Vera, Cavalin Roberta Figueiredo, Lindoso Ana Angélica Bulcão Portela, de Oliveira Rosângela Siqueira

Abstract excerpt

PURPOSE: To describe katG and inhA mutations, clinical characteristics, treatment outcomes and clustering of drug-resistant tuberculosis (TB) in the State of São Paulo, southeast Brazil. METHODS: Mycobacterium tuberculosis isolates from patients diagnosed with drug-resistant TB were screened for mutations in katG and inhA genes by line probe assay and Sanger sequencing, and typed by IS6110-restriction...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bacterial Proteins

Share to Brazil

Share to Drug Resistance, Multiple, Bacterial

Share to Isoniazid

Share to Microbial Sensitivity Tests

Share to Mycobacterium tuberculosis

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed

Identifiers

PMID: 37943394
DOI: 10.1007/s10096-023-04693-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country.PMID 37943394Read ↗

Prevalence of mutations in genes associated with isoniazid resistance in Mycobacterium tuberculosis isolates from re-treated smear-positive pulmonary tuberculosis patients: A meta-analysis.Semantic proximity Read ↗

Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.Semantic proximity Read ↗

Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.Semantic proximity Read ↗

First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.Semantic proximity Read ↗

Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review.Semantic proximity Read ↗

Characteristics and Treatment Outcomes of Isoniazid Mono-Resistant Tuberculosis: A Retrospective Study.Semantic proximity Read ↗

A retrospective cohort study of isoniazid-resistant tuberculosis treatment outcomes and isoniazid resistance-associated mutations in eastern China from 2013 to 2018.Semantic proximity Read ↗

Clinico-microbiological profile and treatment outcomes in patients with isoniazid monoresistant tuberculosis in South IndiaSemantic proximity Read ↗

Whole genome sequencing of isoniazid monoresistant clinical isolates of Mycobacterium tuberculosis reveals novel genetic polymorphisms.Semantic proximity Read ↗

Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.Semantic proximity Read ↗

Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.Semantic proximity Read ↗

Detection and characterization of mutations in genes related to isoniazid resistance in Mycobacterium tuberculosis clinical isolates from Iran.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.